WANBURY
Back to Balance Sheet
|
WANBURY Last 5 Year Net Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹19 Cr | ₹-52 Cr | ₹-198 Cr | ₹-189 Cr | ₹-258 Cr |
What is the latest Net Current Assets ratio of WANBURY ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹19 Cr |
| Mar2024 | ₹-52 Cr |
| Mar2023 | ₹-198 Cr |
| Mar2022 | ₹-189 Cr |
| Mar2021 | ₹-258 Cr |
How is Net Current Assets of WANBURY Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹19 Cr | Positive | |
| Mar2024 | ₹-52 Cr | Negative | |
| Mar2023 | ₹-198 Cr | Negative | |
| Mar2022 | ₹-189 Cr | Negative | |
| Mar2021 | ₹-258 Cr | - | |
Compare Net Current Assets of peers of WANBURY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WANBURY | ₹893.6 Cr | -2.3% | 2.3% | -11.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,513.0 Cr | 0.6% | -2.8% | 6.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,570.0 Cr | 0.4% | 0.1% | 0.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹154,670.0 Cr | 3.4% | 4.3% | 42% | Stock Analytics | |
| CIPLA | ₹111,725.0 Cr | -1.3% | 7% | -7.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,424.0 Cr | -0.2% | 0.4% | -1.4% | Stock Analytics | |
WANBURY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WANBURY | -2.3% |
2.3% |
-11.6% |
| SENSEX | -0.7% |
-2.9% |
-8.9% |
You may also like the below Video Courses